Luke Benvenuto
Overview
Explore the profile of Luke Benvenuto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
317
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laothamatas K, Benvenuto L, Raval M, Kim F, Lemaitre P, Sonett J, et al.
Transplant Proc
. 2025 Feb;
57(3):491-494.
PMID: 40021434
Although active malignancy is a contraindication to lung transplantation, there is increasing uncertainty as to what constitutes "active" malignancy given the rapidly changing therapeutic armamentarium and overall survival of patients...
2.
Asija R, Fuller J, Costa J, Abramov A, Grewal H, Benvenuto L, et al.
Eur J Cardiothorac Surg
. 2025 Feb;
67(2).
PMID: 39900521
Objectives: Single lung transplant (SLT) is an acceptable treatment modality for certain patients with end-stage lung disease. SLT occurs when two appropriate donor lungs are split between recipients ('split singles')...
3.
Sonnick M, Laothamatas K, Furfaro D, DOvidio F, Lemaitre P, Stanifer B, et al.
Transplant Proc
. 2024 Sep;
56(8):1803-1810.
PMID: 39237388
Background: In lung transplant, the United Network for Organ Sharing (UNOS) contains a diagnosis of secondary pulmonary hypertension (SPH). SPH and pulmonary arterial hypertension are treated the same in the...
4.
Diamond J, Benvenuto L, Claridge T, Witek S, Christie J, Singer J, et al.
JHLT Open
. 2024 Jan;
3.
PMID: 38223833
Obesity at the time of lung transplant is associated with decreased survival. How providers manage obesity after lung transplantation is unknown. We performed an international survey of lung transplant providers...
5.
Diamond J, Anderson M, Cantu E, S Clausen E, Shashaty M, Kalman L, et al.
J Heart Lung Transplant
. 2023 Dec;
43(4):633-641.
PMID: 38065239
Background: Primary graft dysfunction (PGD) is the leading cause of early morbidity and mortality after lung transplantation. Accurate prediction of PGD risk could inform donor approaches and perioperative care planning....
6.
Laothamatas K, Benvenuto L, DOvidio F, Arcasoy S
J Heart Lung Transplant
. 2023 Sep;
43(2):350-353.
PMID: 37758007
Many patients with severe COVID-19 have been affected by acute respiratory distress syndrome, which has been associated with increased mortality, and up to 31% of these survivors had persistent interstitial...
7.
Diamond J, Cantu E, Calfee C, Anderson M, S Clausen E, Shashaty M, et al.
Am J Respir Crit Care Med
. 2023 Sep;
209(1):91-100.
PMID: 37734031
Primary graft dysfunction (PGD) is the leading cause of early morbidity and mortality after lung transplantation. Prior studies implicated proxy-defined donor smoking as a risk factor for PGD and mortality....
8.
Anderson M, Cantu E, Shashaty M, Benvenuto L, Kalman L, Palmer S, et al.
Ann Am Thorac Soc
. 2023 Mar;
20(6):825-833.
PMID: 36996331
Low and high body mass index (BMI) are associated with increased mortality after lung transplantation. Why extremes of BMI might increase risk of death is unknown. To estimate the association...
9.
Tao A, Raikhelkar J, Benvenuto L, Topkara V, Brenner K, Fried J, et al.
J Heart Lung Transplant
. 2023 Feb;
42(6):819-827.
PMID: 36806438
Background: Pulmonary function tests (PFT) are a frequent component of heart transplant evaluation. In cardiac surgery abnormal PFTs, especially reduced DLCO, have been associated with poor outcomes. We sought to...
10.
Greissman S, Anderson M, DiMango A, Grewal H, Magda G, Robbins H, et al.
J Heart Lung Transplant
. 2022 Dec;
42(4):480-487.
PMID: 36464610
Background: Blood group O candidates have lower lung transplantation rates despite having the most common blood group. We postulated that waitlist outcomes among these candidates and those with other blood...